{"count": 24, "results": [{"_id": "36060969", "pmid": 36060969, "pmcid": "PMC9428699", "title": "Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome", "journal": "Front Endocrinol (Lausanne)", "authors": ["Xing C", "Zhao H", "Zhang J", "He B"], "date": "2022-08-17T00:00:00Z", "doi": "10.3389/fendo.2022.945609", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "945609", "score": 50274.906, "text_hl": "Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ versus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ plus liraglutide on gonadal and metabolic profiles in @DISEASE_Overweight @DISEASE_MESH:D050177 @@@overweight@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@", "citations": {"NLM": "Xing C, Zhao H, Zhang J, He B. Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome Front Endocrinol (Lausanne). 2022;13():945609. PMID: 36060969", "BibTeX": "@article{36060969, title={Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome}, author={Xing C and Zhao H and Zhang J and He B}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={945609}}"}}, {"_id": "36295882", "pmid": 36295882, "pmcid": "PMC9610220", "title": "The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis", "journal": "Metabolites", "authors": ["Xu C", "He L", "Zhang J", "Xu L", "Dong J", "Liao L"], "date": "2022-10-17T00:00:00Z", "doi": "10.3390/metabo12100979", "meta_date_publication": "2022 Oct 17", "meta_volume": "12", "meta_issue": "10", "meta_pages": "", "score": 50270.37, "text_hl": "Based on these findings, SGLT2i provided the similar antihyperglycemic effects, additional cardiovascular benefits, and a potential @<m>DISEASE_Reproductive_Tract_Infections</m> @DISEASE_MESH:D060737 @@@RTI@@@ risk compared with that of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Xu C, He L, Zhang J, Xu L, Dong J, Liao L. The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis Metabolites. 2022 Oct 17;12(10):. PMID: 36295882", "BibTeX": "@article{36295882, title={The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis}, author={Xu C and He L and Zhang J and Xu L and Dong J and Liao L}, journal={Metabolites}, volume={12}, number={10}}"}}, {"_id": "40349790", "pmid": 40349790, "title": "Metformin alleviates cadmium-induced reproductive toxicity by enhancing mitochondrial biosynthesis and epigenetic modifications in female mice.", "journal": "Toxicol Appl Pharmacol", "authors": ["Zhu J", "Zhu M", "Zhao H", "Lin Y", "Han X", "Tan A", "Wang Y", "Ma Y", "Li J", "Liu Z"], "date": "2025-05-09T00:00:00Z", "doi": "10.1016/j.taap.2025.117390", "meta_date_publication": "2025 May 9", "meta_volume": "500", "meta_issue": "", "meta_pages": "117390", "score": 50261.64, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ alleviates @CHEMICAL_Cadmium @CHEMICAL_MESH:D002104 @@@cadmium@@@-induced @<m>DISEASE_Reproductive_Tract_Infections</m> @DISEASE_MESH:D060737 @@@reproductive toxicity@@@ by enhancing mitochondrial biosynthesis and epigenetic modifications in female @SPECIES_10090 @@@mice@@@.", "citations": {"NLM": "Zhu J, Zhu M, Zhao H, Lin Y, Han X, Tan A, Wang Y, Ma Y, Li J, Liu Z. Metformin alleviates cadmium-induced reproductive toxicity by enhancing mitochondrial biosynthesis and epigenetic modifications in female mice. Toxicol Appl Pharmacol. 2025 May 9;500():117390. PMID: 40349790", "BibTeX": "@article{40349790, title={Metformin alleviates cadmium-induced reproductive toxicity by enhancing mitochondrial biosynthesis and epigenetic modifications in female mice.}, author={Zhu J and Zhu M and Zhao H and Lin Y and Han X and Tan A and Wang Y and Ma Y and Li J and Liu Z}, journal={Toxicol Appl Pharmacol}, volume={500}, pages={117390}}"}}, {"_id": "37569626", "pmid": 37569626, "pmcid": "PMC10418945", "title": "Metformin Ameliorates 2.856 GHz Microwave- Radiation-Induced Reproductive Impairments in Male Rats via Inhibition of Oxidative Stress and Apoptosis", "journal": "Int J Mol Sci", "authors": ["Men J", "Zhang L", "Peng R", "Li Y", "Li M", "Wang H", "Zhao L", "Zhang J", "Wang H", "Xu X", "Dong J", "Wang J", "Yao B", "Guo J"], "date": "2023-07-31T00:00:00Z", "doi": "10.3390/ijms241512250", "meta_date_publication": "2023 Jul 31", "meta_volume": "24", "meta_issue": "15", "meta_pages": "", "score": 50261.17, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Ameliorates 2.856 GHz Microwave- Radiation-Induced @<m>DISEASE_Reproductive_Tract_Infections</m> @DISEASE_MESH:D060737 @@@Reproductive Impairments@@@ in Male @SPECIES_10116 @@@Rats@@@ via Inhibition of Oxidative Stress and Apoptosis", "citations": {"NLM": "Men J, Zhang L, Peng R, Li Y, Li M, Wang H, Zhao L, Zhang J, Wang H, Xu X, Dong J, Wang J, Yao B, Guo J. Metformin Ameliorates 2.856 GHz Microwave- Radiation-Induced Reproductive Impairments in Male Rats via Inhibition of Oxidative Stress and Apoptosis Int J Mol Sci. 2023 Jul 31;24(15):. PMID: 37569626", "BibTeX": "@article{37569626, title={Metformin Ameliorates 2.856 GHz Microwave- Radiation-Induced Reproductive Impairments in Male Rats via Inhibition of Oxidative Stress and Apoptosis}, author={Men J and Zhang L and Peng R and Li Y and Li M and Wang H and Zhao L and Zhang J and Wang H and Xu X and Dong J and Wang J and Yao B and Guo J}, journal={Int J Mol Sci}, volume={24}, number={15}}"}}, {"_id": "34568732", "pmid": 34568732, "pmcid": "PMC8458920", "title": "The effects of gallic acid and metformin on male reproductive dysfunction in diabetic mice induced by methylglyoxal: An experimental study", "journal": "Int J Reprod Biomed", "authors": ["Behdarvand-Margha Z", "Ahangarpour A", "Shahraki M", "Komeili G", "Khorsandi L"], "date": "2021-09-09T00:00:00Z", "doi": "10.18502/ijrm.v19i8.9619", "meta_date_publication": "2021 Aug", "meta_volume": "19", "meta_issue": "8", "meta_pages": "715-724", "score": 50255.47, "text_hl": "The effects of @CHEMICAL_Gallic_Acid @CHEMICAL_MESH:D005707 @@@gallic acid@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on male @<m>DISEASE_Reproductive_Tract_Infections</m> @DISEASE_MESH:D060737 @@@reproductive dysfunction@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10090 @@@mice@@@ induced by @CHEMICAL_Pyruvaldehyde @CHEMICAL_MESH:D011765 @@@methylglyoxal@@@: An experimental study", "citations": {"NLM": "Behdarvand-Margha Z, Ahangarpour A, Shahraki M, Komeili G, Khorsandi L. The effects of gallic acid and metformin on male reproductive dysfunction in diabetic mice induced by methylglyoxal: An experimental study Int J Reprod Biomed. 2021 Aug;19(8):715-724. PMID: 34568732", "BibTeX": "@article{34568732, title={The effects of gallic acid and metformin on male reproductive dysfunction in diabetic mice induced by methylglyoxal: An experimental study}, author={Behdarvand-Margha Z and Ahangarpour A and Shahraki M and Komeili G and Khorsandi L}, journal={Int J Reprod Biomed}, volume={19}, number={8}, pages={715-724}}"}}, {"_id": "37171944", "pmid": 37171944, "title": "Efficacy and Safety of Triple Therapy with SGLT-2 Inhibitor, DPP-4 Inhibitor, and Metformin in Type 2 Diabetes: A Meta-Analysis.", "journal": "Altern Ther Health Med", "authors": ["Li M", "Wang S", "Wang X"], "date": "2023-05-12T00:00:00Z", "meta_date_publication": "2023 May 12", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50249.984, "text_hl": "Efficacy and Safety of Triple Therapy with SGLT-2 Inhibitor, DPP-4 Inhibitor, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@: A Meta-Analysis.", "citations": {"NLM": "Li M, Wang S, Wang X. Efficacy and Safety of Triple Therapy with SGLT-2 Inhibitor, DPP-4 Inhibitor, and Metformin in Type 2 Diabetes: A Meta-Analysis. Altern Ther Health Med. 2023 May 12;():. PMID: 37171944", "BibTeX": "@article{37171944, title={Efficacy and Safety of Triple Therapy with SGLT-2 Inhibitor, DPP-4 Inhibitor, and Metformin in Type 2 Diabetes: A Meta-Analysis.}, author={Li M and Wang S and Wang X}, journal={Altern Ther Health Med}}"}}, {"_id": "40214723", "pmid": 40214723, "title": "Effect of metformin on the endometrial proteome of diet-induced obese mice.", "journal": "J Mol Endocrinol", "authors": ["Malliou-Becher MN", "Turnwald EM", "Skupin L", "Kretschmer T", "Mesaros A", "Purrio M", "Wohlfarth M", "Handwerk M", "Kalis S", "Gründemann D", "Dötsch J", "Germeyer A", "Appel S"], "date": "2025-04-01T00:00:00Z", "doi": "10.1530/JME-24-0098", "meta_date_publication": "2025 Apr 1", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50249.633, "text_hl": "There is evidence that the endometrial function is altered in @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ and/or @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin@@@ resistant @SPECIES_9606 @@@women@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, an insulin-sensitizing drug, has shown potential in treating @<m>DISEASE_Reproductive_Tract_Infections</m> @DISEASE_MESH:D060737 @@@metabolic and reproductive disorders@@@, including @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ (@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@) and may enhance fertility outcomes by improving @DISEASE_Uterine_Diseases @DISEASE_MESH:D014591 @@@endometrial dysfunction@@@. ", "citations": {"NLM": "Malliou-Becher MN, Turnwald EM, Skupin L, Kretschmer T, Mesaros A, Purrio M, Wohlfarth M, Handwerk M, Kalis S, Gründemann D, Dötsch J, Germeyer A, Appel S. Effect of metformin on the endometrial proteome of diet-induced obese mice. J Mol Endocrinol. 2025 Apr 1;():. PMID: 40214723", "BibTeX": "@article{40214723, title={Effect of metformin on the endometrial proteome of diet-induced obese mice.}, author={Malliou-Becher MN and Turnwald EM and Skupin L and Kretschmer T and Mesaros A and Purrio M and Wohlfarth M and Handwerk M and Kalis S and Gründemann D and Dötsch J and Germeyer A and Appel S}, journal={J Mol Endocrinol}}"}}, {"_id": "36290602", "pmid": 36290602, "pmcid": "PMC9598330", "title": "Kelulut Honey Ameliorates Oestrus Cycle, Hormonal Profiles, and Oxidative Stress in Letrozole-Induced Polycystic Ovary Syndrome Rats", "journal": "Antioxidants (Basel)", "authors": ["Kamal DAM", "Ibrahim SF", "Ugusman A", "Mokhtar MH"], "date": "2022-09-22T00:00:00Z", "doi": "10.3390/antiox11101879", "meta_date_publication": "2022 Sep 22", "meta_volume": "11", "meta_issue": "10", "meta_pages": "", "score": 50248.723, "text_hl": "Therefore, we investigated the isolated and combined effects of KH, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, or @CHEMICAL_Clomiphene @CHEMICAL_MESH:D002996 @@@clomiphene@@@ in alleviating oxidative stress and @<m>DISEASE_Reproductive_Tract_Infections</m> @DISEASE_MESH:D060737 @@@reproductive and metabolic abnormalities@@@ in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ (@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@). ", "citations": {"NLM": "Kamal DAM, Ibrahim SF, Ugusman A, Mokhtar MH. Kelulut Honey Ameliorates Oestrus Cycle, Hormonal Profiles, and Oxidative Stress in Letrozole-Induced Polycystic Ovary Syndrome Rats Antioxidants (Basel). 2022 Sep 22;11(10):. PMID: 36290602", "BibTeX": "@article{36290602, title={Kelulut Honey Ameliorates Oestrus Cycle, Hormonal Profiles, and Oxidative Stress in Letrozole-Induced Polycystic Ovary Syndrome Rats}, author={Kamal DAM and Ibrahim SF and Ugusman A and Mokhtar MH}, journal={Antioxidants (Basel)}, volume={11}, number={10}}"}}, {"_id": "37701721", "pmid": 37701721, "pmcid": "PMC10494929", "title": "Effect of Hypoglycemic Drugs on Kisspeptin Expression in the Hypothalamic Arcuate Nucleus of PCOS Rats", "journal": "Diabetes Metab Syndr Obes", "authors": ["Zheng P", "Lu Y", "Tang Y", "Xu F", "Wang L", "Qian R", "Hui C", "Xu Q", "He J", "Deng D"], "date": "2023-09-07T00:00:00Z", "doi": "10.2147/DMSO.S421911", "meta_date_publication": "2023", "meta_volume": "16", "meta_issue": "", "meta_pages": "2717-2732", "score": 50246.36, "text_hl": "The expression of hypothalamic @GENE_KISS1 @GENE_289023 @@@Kiss1@@@ may play an important role in the pathogenesis of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@, and @CHEMICAL_Acarbose @CHEMICAL_MESH:D020909 @@@acarbose@@@ may reduce the expression of hypothalamic @GENE_KISS1 @GENE_289023 @@@Kiss1@@@ by improving @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@, thereby improving @<m>DISEASE_Reproductive_Tract_Infections</m> @DISEASE_MESH:D060737 @@@reproductive and metabolic disorders@@@ in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Zheng P, Lu Y, Tang Y, Xu F, Wang L, Qian R, Hui C, Xu Q, He J, Deng D. Effect of Hypoglycemic Drugs on Kisspeptin Expression in the Hypothalamic Arcuate Nucleus of PCOS Rats Diabetes Metab Syndr Obes. 2023;16():2717-2732. PMID: 37701721", "BibTeX": "@article{37701721, title={Effect of Hypoglycemic Drugs on Kisspeptin Expression in the Hypothalamic Arcuate Nucleus of PCOS Rats}, author={Zheng P and Lu Y and Tang Y and Xu F and Wang L and Qian R and Hui C and Xu Q and He J and Deng D}, journal={Diabetes Metab Syndr Obes}, volume={16}, pages={2717-2732}}"}}, {"_id": "36322951", "pmid": 36322951, "title": "Therapeutic metformin concentrations positively regulate proliferation in endometrial epithelial cells via mTOR activation and augmented mitochondrial strength.", "journal": "Can J Physiol Pharmacol", "authors": ["Imran M", "Sachdeva G", "Menon S", "Das D", "Davuluri S", "Acharya K", "Chaudhari U"], "date": "2023-01-01T00:00:00Z", "doi": "10.1139/cjpp-2022-0307", "meta_date_publication": "2023 Jan 1", "meta_volume": "101", "meta_issue": "1", "meta_pages": "52-64", "score": 50246.027, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, an antidiabetic drug, has recently been repositioned in the treatment of several @DISEASE_Congenital_Hereditary_and_Neonatal_Diseases_and_Abnormalities @DISEASE_MESH:D009358 @@@nondiabetic disorders@@@, including @<m>DISEASE_Reproductive_Tract_Infections</m> @DISEASE_MESH:D060737 @@@reproductive disorders@@@ such as @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovarian syndrome@@@, where it improves endometrial functions. ", "citations": {"NLM": "Imran M, Sachdeva G, Menon S, Das D, Davuluri S, Acharya K, Chaudhari U. Therapeutic metformin concentrations positively regulate proliferation in endometrial epithelial cells via mTOR activation and augmented mitochondrial strength. Can J Physiol Pharmacol. 2023 Jan 1;101(1):52-64. PMID: 36322951", "BibTeX": "@article{36322951, title={Therapeutic metformin concentrations positively regulate proliferation in endometrial epithelial cells via mTOR activation and augmented mitochondrial strength.}, author={Imran M and Sachdeva G and Menon S and Das D and Davuluri S and Acharya K and Chaudhari U}, journal={Can J Physiol Pharmacol}, volume={101}, number={1}, pages={52-64}}"}}]}